Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.20% | -4.65% | 9.07% | 51.42% | 57.32% |
| Total Depreciation and Amortization | 6.14% | 5.76% | 5.07% | -1.64% | -2.20% |
| Total Amortization of Deferred Charges | -8.47% | -7.87% | -7.57% | -7.96% | -62.40% |
| Total Other Non-Cash Items | 129.70% | 75.96% | 26.17% | -16.97% | -43.65% |
| Change in Net Operating Assets | 287.91% | 629.30% | 1,354.16% | 294.92% | 329.28% |
| Cash from Operations | 36.90% | 53.58% | 58.40% | 34.71% | 21.47% |
| Capital Expenditure | 72.53% | 85.74% | 73.11% | 4.15% | 12.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,365.59% | -816.90% | -18.27% | -11.37% | 15.18% |
| Cash from Investing | -1,326.22% | -282.88% | 41.25% | 69.69% | 75.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.00% | -16.67% | -8.33% | 0.00% | 92.78% |
| Issuance of Common Stock | -26.55% | -47.29% | 56.98% | 209.20% | 987.50% |
| Repurchase of Common Stock | 5.82% | -11.98% | -20.30% | 90.91% | 95.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.26% | -106.31% | 17.71% | 85.80% | 93.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.37% | -35.65% | 111.90% | 313.53% | 231,164.65% |